Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Manal L. Louka"'
Autor:
Rehab A. Hasan, Manal L. Louka, Maggie M. Ramzy, Ghada A. Abdel-Latif, Mona F. Schaalan, Noura F. Elmongy, Azza H. Abd Elwahab
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-17 (2020)
Scientific Reports
Scientific Reports
Cyclophosphamide (CP) is a chemotherapeutic agent that induces oxidative stress causing multiple organ damage. Sacubitril/valsartan, is a combined formulation of neprilysin inhibitor (sacubitril) and angiotensin II receptor blocker (valsartan), that
Publikováno v:
Indian Journal of Dermatology, Vol 56, Iss 6, Pp 673-677 (2011)
Background : Most atopic dermatitis (AD) patients have elevated serum immunoglobulin E (IgE). Impaired folic acid (FA) metabolism was found to reduce the intracellular methyl donor pool, associated with a higher prevalence of atopy. Aim : To assess s
Externí odkaz:
https://doaj.org/article/08b19872bf8542f6adf1771afe915307
Autor:
Christine Kamal Thabet Gobrial, Mona Hussien Raafat Ahmed, Alaa Abdel-Hakim Abdel-Magid, Manal L. Louka, Marwa Abdallah
Publikováno v:
QJM: An International Journal of Medicine. 114
Background Vitiligo is acquired depigmentary disorder characterized by destruction of the epidermal melanocytes leading to the loss of the skin color. Oxidative stress has a major role in the aetiopathogenesis and in melanocytic destruction due to it
Publikováno v:
Gene. 844:146828
Sorafenib is an FDA approved chemotherapeutic against hepatocellular carcinoma (HCC) yet associated with various resistance mechanisms. The role of high glucose status on sorafenib action is still to be elucidated. This study clarifies such interacti
Autor:
Manal L. Louka, Ahmed Gaballah, Mai Atef Abd El Mageed, Marwa Badr, Hesham Elghazaly, Hebatallah Said
Publikováno v:
Journal of Cellular Biochemistry. 120:3459-3466
Breast cancer is the second most common cancer diagnosed worldwide. Human epidermal growth factor receptor 2 (HER2)-positive breast cancer represents about 20% to 30% of all breast cancers. Trastuzumab is used in the treatment of HER2-positive breast
Publikováno v:
Gene. 653:65-71
Worldwide, hepatocellular carcinoma (HCC) is the major subtype of primary liver cancers. HCC is typically diagnosed late in its course. With respect to cancer, the genomic actions of vitamin D are mediated through binding to the Vitamin D Receptor (V
Autor:
Manal L. Louka, Samar K. Kassim, Hanan H. Shehata, Maha M. Sallam, Sanaa M. Kamal, L.M. Nabegh, M.M. Salib
Publikováno v:
Meta Gene. 13:63-69
Objectives Hepatitis C virus (HCV) infection in Egypt is the most serious health problem, where 10%–15% of the population is infected. The severity of the disease and diagnostic decision-making is evaluated by liver biopsy; an invasive technique wi
Autor:
Abdelrahman M. Naiem, Mohamed A. Abdelghany, Ahmed E. Abdelhalim, Manal L. Louka, Ahmed M. Fawzy, Mustafa F. Elseknedy
Publikováno v:
Gene. 629:108-116
Hepatocellular carcinoma (HCC) is a primary liver malignancy, and is now the six most common in between malignancies. Early diagnosis of HCC with prompt treatment increases the opportunity of patients to survive. With the advances in understanding th
Publikováno v:
Meta Gene. 12:62-67
Background Type 2 diabetes mellitus (DM) is a chronic metabolic disease. The aim of this study was to evaluate the expression of FOXO1 and its target CCN3 in patients with type 2 DM in a trial to explore the molecular mechanism underlying β cell fai
Publikováno v:
Gene Reports. 7:184-188
Context Elevated expression of galectins correlates with neoplastic progression in certain malignancies. Matrix Metalloproteinases (MMPs) have been implicated in metastatic and angiogenic processes. Gal-1 promoted tumor invasion in oral cancer cell l